BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2021
View Archived Issues
MiR-30c mimics ameliorate liver fibrosis in vivo
Read More
Targeting tenascin-C could reduce the effects of retinal ischemia
Read More
FDA clears IND for investigational microbiome therapeutic SER-155
Read More
Immutep and Merck KGaA collaborate on phase I/II study of eftilagimod alpha plus bintrafusp alfa
Read More
Viracta initiates global pivotal study of nanatinostat plus valganciclovir in EBV+ lymphoma
Read More
Novel inhalable liposome formulations of antiviral drugs against COVID-19
Read More
Revolution Medicines discloses SOS1 inhibitors
Read More
Heptares Therapeutics patents GPR52 agonists
Read More
Dana-Farber Cancer Institute presents new PROTACs
Read More
Ventyx Biosciences synthesizes new TYK2 ligands
Read More
Valo Early Discovery identifies new HDAC8 inhibitors
Read More
NIH announces first-in-human study of FluMos-v1 universal influenza vaccine
Read More
Copeptin is a prognostic marker in schizophrenia spectrum disorder
Read More
Diverse cohort expands diabetes genomics
Read More
Transine Therapeutics secures funding to advance its novel class of therapeutic RNAs
Read More
Irisin and nucleobindin-2 predict cardiovascular risk in patients with NFAI
Read More
ATG3 gene is implicated in the development of NAFLD
Read More
N-803 shows safety and efficacy in combination with rituximab in iNHL
Read More
MCAD as novel therapeutic target for glioblastoma
Read More